Sticking and patching: tuning and anchoring cyclometallated ruthenium(II) complexes by Ertl, C. D. et al.
Dalton Trans. RSCPublishing 
ARTICLE	
This	journal	is	©	The	Royal	Society	of	Chemistry	2013	 J.	Name.,	2013,	00,	1-3	|	1 	
Cite this: DOI: 10.1039/x0xx00000x 
Received 00th January 2012, 
Accepted 00th January 2012 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
S t i c k i n g  a n d  p a t c h i n g :  t u n i n g  a n d  a n c h o r i n g  
c y c l o m e t a l l a t e d  r u t h e n i u m ( I I )  c o m p l e x e s  
Cathrin D. Ertl,a Daniel P. Ris,a Stefan C. Meier,b Edwin C. Constablea , Catherine 
E. Housecroft,*a Markus Neuburgera and Jennifer A. Zampesea  
This paper is dedicated to the memory of Kenneth (Ken) Wade, a pioneer in his field, and whose creative 
thinking and ability to encourage his students to think set him apart in the scientific world. 
A series of [Ru(bpy)2(C^N)][PF6] (HC^N = 2-phenylpyridine derivative) complexes functionalized in the 
cyclometallating C^N phenyl ring with F, Me, OMe, CO2Me, StBu, SO2Me (ligands H1–H6) or in the C^N 
pyridine ring with 4-CO2Me or 4-C6H4P(O)(OEt)2 substituents (ligands H7 or H9) have been prepared 
and characterized; representative crystal structures confirm the structural features of the complexes. 
When the C^N ligand contains a CO2H substituent (ligand H28), deprotonation in addition to 
cyclometallation occurs to give a neutral, zwitter-ionic complex [Ru(bpy)2(8)]. The synthesis of the 
cationic complexes requires addition of a silver(I) salt (AgPF6) to abstract Cl– from cis-[Ru(bpy)2Cl2] and 
1H NMR spectroscopic data are consistent with interactions between Ag+ and the coordinated C^N 
ligand in [Ru(bpy)2(C^N)]+. The absorption spectra of [Ru(bpy)2(C^N)][PF6] (C^N = 1–6) are similar, but 
the introduction of the anchoring domains in [Ru(bpy)2(C^N)][PF6] with C^N = 7 or 9 enhances the 
absorption response; the greatest influence is observed in [Ru(bpy)2(9)]+ with the introduction of the 4-
C6H4P(O)(OEt)2 substituent. Trends in emission and electrochemical behaviours of the complexes are 
interpreted in terms of the influence of the electronic properties of the C^N ligand substituents on the 
energies of the HOMO which is localized on the C^N ligand and Ru centre. This study provides an 
optimized synthetic route to the phosphonate ester derivative [Ru(bpy)2(9)][PF6], designed to anchor 
to a semiconductor surface; this complex also exhibits the most favourable absorption properties 
among the complexes studied. 
 
Introduction	
The tris-chelate [Ru(bpy)2(ppy)]+ (bpy = 2,2'-bipyridine, Hppy 
= 2-phenylpyridine) is an archetype cyclometallated analogue1,2 
of [Ru(bpy)3]2+. Over the last few years, there has been a 
renewed interest in cyclometallated ruthenium(II) complexes in 
the context of their application in n-type dye-sensitized solar 
cells (DSCs). The replacement of thiocyanate ligands in 
conventional ruthenium(II) sensitizers by cyclometallating 
ligands3,4,5 was first established by van Koten and coworkers6 
using a C^N^N donor set. In 2009, Grätzel and coworkers 
reported a 10.1% global efficiency for a DSC containing 
[Ru(dcbpy)2(F2ppy)]+ (dcbpy = 2,2'-bipyridine-4,4'-
dicarboxylic acid, H(F2ppy) = 2-(2,4-difluorophenyl)pyridine).7 
Replacing thiocyanate by an anionic C^N ligand provides a 
means of tuning the HOMO–LUMO properties of the dyes. The 
HOMO of a [Ru(N^N)2(C^N)]+ complex is localized on the 
metal and C^N ligand,8 and therefore the energy of the HOMO 
can be altered by introducing electron-withdrawing or electron-
donating substituents into the phenyl ring. This strategy has 
been successfully applied to tune orbital energies and emission 
properties of cyclometallated iridium(III) complexes in organic 
light-emitting diodes (OLEDs) and light-emitting 
electrochemical cells (LECs).9 An advantage of 
[Ru(N^N)2(C^N)]+ dyes in DSCs is the significant red-shift in 
their absorption spectra yielding improved photoresponse. The 
potential for enhanced photon-to-current conversion 
efficiencies has prompted active exploration of cyclometallated 
ruthenium(II) sensitizers for n-type DSCs.8,10,11 The effects of 
combining [Ru(N^N)2(C^N)]+ sensitizers with the cobalt-based 
redox shuttle [Co(dmbpy)3]3+/2+ (dmbpy = 4,4'-dimethyl-2,2'-
bipyridine) have also recently been reported.12  
 In [Ru(N^N)2(C^N)]+ dyes for n-type DSCs, the 
cyclometallating domain constitutes the ancillary ligand. 
However, the localization of the HOMO on the C^N ligand and 
ruthenium means that [Ru(N^N)2(C^N)]+ complexes are of 
potential interest as sensitizers in either p-type or tandem 
DSCs.13 In a p-type DSC, excitation of the anchored dye is 
ARTICLE	 Journal	Name	
2 	|	J.	Name.,	2012,	00,	1-3	 This	journal	is	©	The	Royal	Society	of	Chemistry	2012	
followed by rapid hole injection into a p-type semiconductor 
(e.g. NiO). This is the inverse of electron injection from dye to 
n-type semiconductor, leading to contrary frontier orbital 
requirements of dyes in n- and p-type DSCs. The viability of 
ruthenium(II) complexes containing cyclometallated ligands 
(both C^N and N^C^N) for NiO sensitization has been 
established,14,15 but investigations of these dyes remain limited.  
 We report here an investigation of two families of 
[Ru(N^N)2(C^N)]n+ (n = 0, 1) complexes with various C^N 
ligand-functionalization (Schemes 1 and 2) and the 
consequential effects on the absorption and electrochemical 
properties. Functionalization includes the introduction of 
different anchoring domains (Scheme 2). Both carboxylic and 
phosphonic acid substituents are ubiquitous among anchoring 
groups to attach sensitizers to TiO2 in n-type DSCs, and these 
anchors are also appropriate for adsorption of dyes on p-type 
NiO.16 In the current work, we focus on a phosphonate ester 
rather than phosphonic acid-functionalized C^N ligand 
(Scheme 2). Hydrolytic deprotection of the ruthenium-bound 
diethyl phosphonates does not always proceed to 
completion17,18,19,20,21 and phosphonate esters have been 
successfully used to modify TiO2 surfaces, negating the need 
for this step.22,23  
 
Experimental	
General 
Microwave reactions were carried out in a Biotage Initiator 8 
reactor. 1H, 13C and 31P NMR spectra were recorded on Bruker 
Avance III-250, III-400 or III-500 spectrometers at 295 K. The 
chemical shifts were referenced with respect to residual solvent 
peaks (∂(TMS) = 0 ppm). IR spectra were recorded on a Perkin 
Elmer FT-IR Spectrum Two spectrometer using solid samples. 
ESI mass spectra (solution samples in MeCN) and high 
resolution ESI-MS were measured on Bruker Esquire 3000plus 
and Bruker maXis 4G instruments, respectively; LC-ESI-MS 
and MALDI-TOF mass spectra  employed a combination of 
Shimadzu (LC) and Bruker AmaZon X instruments or a 
Microflex Bruker Daltonics instrument, respectively. An 
Agilent 8453 spectrophotometer was used to record absorption 
spectra, and photoluminescence measurements were performed 
on a Shimadzu RF-5301 PC spectrofluorometer.  
 Electrochemical measurements were made with a CHI 900B 
instrument using a glassy carbon working electrode, platinum-
wire auxiliary electrode, and silver-wire pseudo-reference 
electrode. Redox potentials were determined by both cyclic and 
square wave voltammetry. HPLC grade, argon degassed MeCN 
solutions (≈10–4 mol dm–3) of samples were used in the 
presence of 0.1 M [nBu4N][PF6] as supporting electrolyte; the 
scan rate was 0.1 V s–1 and ferrocene (Fc+/Fc) was the internal 
standard. 
 The compounds [Ru(bpy)2(ppy)][PF6],1 H1,24  H2,25 H3,25 
H4,26 H5,27 H6,27 H7,28 H288 were prepared by literature 
methods.  
2-Phenyl-4-(4-bromophenyl)pyridine-6-carboxylic acid 
N-Phenacylpyridinium chloride (3.79 g, 162 mmol), (E)-4-(4-
bromophenyl)-2-oxobut-3-enoic acid (4.14 g, 16.2 mmol) and 
NH4OAc (12.5 g, 162 mmol) were dissolved in H2O (120 mL) 
and the solution heated at 100°C for 16 h. The precipitate was 
separated by filtration and washed with water and acetone. 
After drying under vacuum, the product was obtained as an off-
white solid (2.09 g, 5.9 mmol, 36%). 1H NMR (250 MHz, 
DMSO-d6) δ / ppm 8.24-8.19 (m, 2H, HF2), 8.16 (d, J = 1.7 Hz, 
1H, HE5/E3), 8.05 (d, J = 1.7 Hz, 1H, HE3/E5), 7.91-7.85 (m, 2H, 
HG2/G3), 7.77-7.65 (m, 2H, HG3/G2), 7.55-7.34 (m, 3H, HF3+F4), 
7.06 (br, 1H, HCOOH). The product was used in the next step 
without further characterization. 
2-Phenyl-4-(4-bromophenyl)pyridine  
2-Phenyl-4-(4-bromophenyl)pyridine-6-carboxylic acid (750 
mg, 2.12 mmol) was suspended in ethane-1,2-diol (200 mL) 
and heated at 200°C for 24 h. The resulting black solution was 
poured into water (500 mL) and extracted with CH2Cl2 (3 × 20 
mL). The organic layer was concentrated and purified by flash 
column chromatography (SiO2, EtOAc/cyclohexane 1:4). The 
product was initially a brown oil that solidified on standing to 
give an off-white solid (440 mg, 1.42 mmol, 67%). 1H NMR 
(500 MHz, CDCl3) δ/ppm: 8.75 (dd, J = 5.2, 0.8 Hz, 1H, HE6), 
8.07 – 8.02 (m, 2H, HF2), 7.89 (dd, J = 1.9, 0.8 Hz, 1H, HE3), 
7.64 (m, 2H, HG3), 7.56 (m, 2H, HG2), 7.50 (m, 2H, HF3), 7.46 
(m, 1H, HF4), 7.43 (dd, J = 5.2, 1.8 Hz, 1H, HE5). 13C{1H} 
NMR (126 MHz, CDCl3) δ/ppm: 158.2 (CE2), 150.0 (CE6), 
148.6 (CE4), 139.0 (CF1), 137.4 (CG1), 132.5 (CG3), 129.5 (CF4), 
129.0 (CF3), 128.8 (CG2), 127.2 (CF2), 123.8 (CG4), 120.1 (CE5), 
118.7 (CE3). LC-ESI-MS m/z: 310.0 [M+H]+ (calc. 310.0). 
Found C 65.85, H 4.19, N 4.48; C17H12BrN requires C 65.83, H 
3.90, N 4.52. 
Compound H9  
2-Phenyl-4-(4-bromophenyl)pyridine (400 mg, 1.29 mmol), 
Pd(PPh3)4 (149 mg, 0.129 mmol) and Cs2CO3 (882 mg, 2.71 
mmol) were added to anhydrous THF (10 mL) in a microwave 
vial under argon. Diethyl phosphite (712 mg, 5.16 mmol) was 
added and the reaction mixture heated at 110 °C for 90 min in a 
microwave reactor. The reaction mixture was filtered giving a 
yellow solution. Solvent was evaporated under reduced 
pressure, the brown residue dissolved in CH2Cl2 (10 mL) and 
the mixture stirred with charcoal for 30 min. Filtration through 
Celite prior to removal of the solvent gave a bright yellow oily 
residue. This was dissolved in acetone (5 mL) and filtered 
through a short silica plug eluting with acetone/cyclohexane 
2:3. Flash chromatography (SiO2, EtOAc) followed by 
preparative TLC (SiO2, cyclohexane/acetone 2:3) yielded H9 as 
a white solid (268 mg, 0.729 mmol, 57%). 1H NMR (500 MHz, 
295 K, CD3CN) δ/ppm: 8.73 (dd, J = 5.1, 0.9 Hz, 1H, HE6), 
8.16-8.14 (m, 2H, HF2), 8.12 (dd, J = 1.7, 0.8 Hz, 1H, HE3), 
7.95-7.87 (m, 4H, HG2+G3), 7.60 (dd, J = 5.1, 1.7 Hz, 1H, HE5), 
7.54-7.45 (m, 3H, HF3+F4), 4.15-4.04 (m, 4 H, HPO(OCH2Me)2), 
1.30 (td, J = 7.0, 0.6 Hz, 6H, H PO(OCH2Me)2). 13C{1H} NMR (126 
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MHz, CD3CN) δ/ppm: 158.5 (CE2), 151.0 (CE6), 149.1 (CE4), 
142.9 (d, J = 3.2 Hz, CG1), 139.8 (CF1), 133.2 (d, J = 10 Hz, 
CG3), 130.7 (d, J = 187.8 Hz, CG4), 130.3 (CF4), 129.7 (CF3), 
128.4 (d, J = 14.9 Hz, CG2), 128.0 (CF2), 121.5 (CE5), 119.6 
(CE3), 63.1 (d, J = 5.6 Hz, 2C, CPO(OCH2Me)2), 16.7 (d, J = 6.2 
Hz, 2C, CPO(OCH2Me)2). 31P{1H} NMR (162 MHz, CD3CN) δ / 
ppm: 17.1. ESI MS m/z: 368.4 [M+H]+ (calc. 368.1), 390.4 
[M+Na]+ (calc. 390.1). Found C 67.24, H 6.24, N 3.58; 
C21H22NO3P·0.5H2O requires C 67.01, H 6.16, N 3.81. 
[Ru(bpy)2(ppy)][PF6] 
The compound was prepared as previously reported.1 For 
comparative purposes, the NMR spectra were recorded and 
assigned as follows. 1H NMR (500 MHz, CD3CN) δ/ppm: 8.45 
(dt, J = 8.3, 1.1 Hz, 1H, HA3), 8.38 (ddd, J = 8.2, 1.4, 0.8 Hz, 
1H, HB3), 8.32 (m, 1H, HC3), 8.30 (m, 1H, HD3), 8.05 (ddd, J = 
5.7, 1.6, 0.8 Hz, 1H, HB6), 8.01 (dt, J = 8.3, 1.2 Hz, 1H, HE3), 
7.97 (ddd, J = 8.2, 7.6, 1.6 Hz, 1H, HA4), 7.85-7.76 (m, 5H, 
HA6+F3+C4+B4+D6), 7.77 (ddd, J = 8.2, 7.7, 1.4 Hz, 1H, HD4), 7.72 
(ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HC6), 7.68 (ddd, J = 8.2, 7.4, 1.6 
Hz, 1H, HE4), 7.56 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HE6), 7.40 
(ddd, J = 7.6, 5.4, 1.2 Hz, 1H, HA5), 7.22-7.18 (m, 3H, 
HC5+D5+B5), 6.92 (ddd, J = 7.2, 5.7, 1.5 Hz, 1H, HE5), 6.89 (ddd, 
J = 7.4, 7.3, 1.3 Hz, 1H, HF4), 6.82 (dt, J = 7.3, 1.4 Hz, 1H, 
HF5), 6.41 (ddd, J = 7.4, 1.3, 0.5 Hz, 1H, HF6). 13C{1H} NMR 
(126 MHz, CD3CN) δ/ppm: 193.8 (CF1), 168.3 (CE2), 158.7 
(CB2), 157.8 (CC2), 157.6 (CD2), 156.1 (CA2), 155.0 (CB6), 151.3 
(CE6), 151.2 (CD6), 151.0 (CC6), 150.0 (CA6), 146.6 (CF2), 137.2 
(CA4), 136.7 (CE4), 136.2 (CF6), 135.9 (CB4), 134.7 (CC4), 134.5 
(CD4), 129.4 (CF5), 128.0 (CA5), 127.3 (CC5), 127.2 (CB5), 127.0 
(CD5), 125.8 (CF3), 124.4 (CB3), 124.1 (CA3), 124.0 (CD3), 123.9 
(CC3), 123.2 (CE5), 121.8 (CF4), 119.8 (CE3). 
[Ru(bpy)2(1)][PF6] 
cis-[Ru(bpy)2Cl2] (50.0 mg, 0.103 mmol), H1 (49.0 mg, 0.283 
mmol) and AgBF4 (40.2 mg, 0.206 mmol) were dissolved in 
CH2Cl2 (7.5 mL) and the dark purple solution heated at reflux 
for 24 h. The reaction mixture was filtered through Celite to 
remove precipitated AgCl. The dark red-purple solution was 
concentrated under reduced pressure. n-Hexane (50 mL) was 
added to the dark purple oily residue and the mixture was left in 
a refrigerator overnight. The solution was decanted to separate 
a dark purple-red precipitate which was dried under reduced 
pressure. The solid was dissolved in MeCN (10 mL) and an 
excess of aqueous NH4PF6 was added. The precipitate was 
collected by filtration, washed with H2O and Et2O and 
redissolved with CH2Cl2. The solution was concentrated under 
reduced pressure and purified by flash chromatography (Al2O3, 
acetone/toluene 1:1 changing to 4:1 and pure acetone). 
[Ru(bpy)2(1)][PF6] was obtained as a dark purple solid (39 mg, 
0.053 mmol, 52%). 1H NMR (500 MHz, CD3CN) δ/ppm: 8.45 
(dt, J = 8.2, 1.1 Hz, 1H, HA3), 8.38 (dt, J = 8.2, 1.2 Hz, 1H, 
HB3), 8.33 (m, 1H, HC3), 8.31 (m, 1H, HD3), 8.04 (ddd, J = 5.7, 
1.6, 0.8 Hz, 1H, HB6), 7.98 (m, 2H, HA4+E3), 7.88-7.79 (m, 5H, 
HF3+ C4+A6+B4+D4), 7.78 (ddd, J = 5.8, 1.5, 0.8 Hz, 1H, HD6), 7.71 
(ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HC6), 7.68 (ddd, J = 8.2, 7.4, 1.6 
Hz, 1H, HE4), 7.54 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HE6), 7.41 
(ddd, J = 7.6, 5.4, 1.2 Hz, 1H, HA5), 7.22 (m, 3H, HC5+D5+B5), 
6.92 (ddd, J = 7.3, 5.7, 1.4 Hz, 1H, HE5), 6.60 (ddd, J = 9.3, 8.5, 
2.7 Hz, 1H, HF4), 6.05 (dd, J = 9.6, 2.7 Hz, 1H, HF6); 13C{1H} 
NMR (126 MHz, CD3CN) δ/ppm: 198.9 (d, J = 3.2 Hz, CF1), 
167.3 (CE2), 164.0 (d, J = 252 Hz, CF5), 158.6 (CB2), 157.9 
(CC2), 157.6 (CD2), 156.1 (CA2), 155.1 (CB6), 151.3 (CE6), 151.2 
(CD6), 151.1 (CC6), 150.2 (CA6), 142.9 (d, J = 1.9 Hz, CF2), 
137.5 (CA4), 136.8 (CE4), 136.1 (CB4), 135.1 (CC4), 135.0 (CD4), 
128.0 (CA5), 127.5 (CC5), 127.3 (CB5), 127.2 (CD5), 126.8 (d, J = 
8.7 Hz, CF3), 124.4 (CB3), 124.2 (CA3), 124.1 (2C, CC3+D3), 
123.1 (CE5), 121.2 (d, J = 14.4 Hz CF6), 119.7 (CE3), 108.7 (d, J 
= 23.5 Hz, CF4). 19F{1H} NMR (377 MHz, CD3CN) δ/ppm: –
72.9 (d, J = 706 Hz, 6F, [PF6]–), –114.5 (s, 1F, FF5). ESI-MS 
m/z: 586.4 [M–PF6]+ (calc. 586.1). UV-Vis (MeCN, 1 × 10–5 
M) λ/nm (ε/dm3 mol−1 cm−1): 248 (33900), 296 (61300), 368 
(11600), 399 (11200), 485 (9000), 538 (10200). Emission 
(MeCN, c = 5 × 10-5 M, λexc = 560 nm): λmaxem = 776 nm. 
Found C 49.77, H 3.53, N 9.36; C31H23F7N5PRu·H2O requires 
C 49.74, H 3.37, N 9.36.  
[Ru(bpy)2(2)][PF6] 
cis-[Ru(bpy)2Cl2] (120 mg, 0.248 mmol), H2 (92.2 mg, 0.09 
mL, 0.545 mmol) and AgPF6 (138 mg, 0.545 mmol) were 
dissolved in CH2Cl2/MeOH (3:1, 16 mL) and the dark purple 
solution heated at reflux for 2 h. The mixture was filtered 
through Celite and the filtrate concentrated under reduced 
pressure and subjected to flash chromatography (Al2O3, 
acetone/pentane 1:2 changing to pure acetone). Fractions were 
combined and solvent volume reduced; n-hexane was then 
added to precipitate a dark purple solid. CH2Cl2 (20 mL) was 
added and the solution was layered with Et2O (100 mL). 
[Ru(bpy)2(2)][PF6] precipitated as a dark purple crystalline 
solid after a few days (108 mg, 0.149 mmol, 60%). 1H NMR 
(500 MHz, CD3CN) δ/ppm: 8.44 (dt, J = 8.2, 1.1 Hz, 1H, HA3), 
8.37 (ddd, J = 8.2, 1.3, 0.7 Hz, 1H, HB3), 8.32 (m, 1H, HC3), 
8.30 (m, 1H, HD3), 8.07 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HB6), 
7.97 (ddd, J = 8.2, 7.6, 1.6 Hz, 1H, HA4), 7.95 (dt, J = 8.3, 1.2 
Hz, 1H, HE3), 7.83-7.76 (m, 5H, H A6+C4+B4+D6+D4), 7.73 (d, J = 
7.8 Hz, 1H, HF3), 7.71 (ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HC6), 7.65 
(ddd, J = 8.2, 7.4, 1.6 Hz, 1H, HE4), 7.51 (ddd, J = 5.7, 1.6, 0.8 
Hz, 1H, HE6), 7.39 (ddd, J = 7.6, 5.4, 1.2 Hz, 1H, HA5), 7.22-
7.18 (m, 3H, HC5+D5+B5), 6.87 (ddd, J = 7.3, 5.7, 1.4 Hz, 1H, 
HE5), 6.71 (ddd, J = 8.0, 1.9, 0.7 Hz, 1H, HF4), 6.24 (dt, J = 1.9, 
0.6 Hz, 1H, HF6), 2.03 (s, 3H, HMe). 13C{1H} NMR (126 MHz, 
CD3CN) δ/ppm: 193.8 (CF1), 168.3 (CE2), 158.7 (CB2), 157.8 
(CC2), 157.7 (CD2), 156.1 (CA2), 155.0 (CB6), 151.2 (CE6), 151.1 
(CD6), 150.9 (CC6), 150.0 (CA6), 143.8 (CF2), 139.1 (CF5), 137.2 
(CA4), 136.9 (CF6), 136.6 (CE4), 135.8 (CB4), 134.6 (CC4), 134.4 
(CD4), 128.0 (CA5), 127.3 (CC5), 127.1 (CB5), 127.0 (CD5), 125.0 
(CF3), 124.4 (CB3), 124.1 (CA3), 123.93 (CD3), 123.88 (CC3), 
123.0 (CF4), 122.7 (CE5), 119.4 (CE3), 21.8 (CMe). ESI MS m/z: 
582.4 [M–PF6]+ (calc. 582.1). UV-Vis (MeCN, 1 × 10–5 M) 
λ/nm (ε/dm3 mol−1 cm−1): 249 (36600), 296 (64300), 372 
(11900), 405 (11300), 490 (8500), 548 (9500). Emission 
(MeCN, 5 × 10–5 M, λexc = 575 nm): λmaxem = 805 nm. Found C 
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52.62, H 3.95, N 9.66; C32H26F6N5PRu requires C 52.90, H 
3.61, N 9.64. 
[Ru(bpy)2(3)][PF6] 
cis-[Ru(bpy)2Cl2] (150 mg, 0.310 mmol), H3 (126 mg, 0.681 
mmol) and AgPF6 (172 mg, 0.681 mmol) were dissolved in 
CH2Cl2/MeOH (3:1, 16 mL) and the dark purple solution 
heated at reflux for 2 h. The mixture was filtered through Celite 
and the filtrate concentrated under reduced pressure and 
subjected to flash chromatography (basic Al2O3, 
EtOAc/cyclohexane 1:4 then pure CH2Cl2). The fractions were 
concentrated, and n-hexane was added to precipitate dark 
purple [Ru(bpy)2(3)][PF6] (99 mg, 0.133 mmol, 43%). 1H NMR 
(500 MHz, CD3CN) δ/ppm: 8.45 (dt, J = 8.2, 1.1 Hz, 1H, HA3), 
8.37 (ddd, J = 8.2, 1.4, 0.8 Hz, 1H, HB3), 8.31 (m, 1H, HC3), 
8.30 (m, 1H, HD3), 8.09 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HB6), 
7.97 (ddd, J = 8.2, 7.5, 1.6 Hz, 1H, HA4), 7.86 (m, 2H, HE3+A6), 
7.83-7.76 (m, 5H, H D6+B4+D4+F3+C4), 7.73 (ddd, J = 5.7, 1.5, 0.8 
Hz, 1H, HC6), 7.62 (ddd, J = 8.2, 7.4, 1.6 Hz, 1H, HE4), 7.48 
(ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HE6), 7.40 (ddd, J = 7.6, 5.4, 1.2 
Hz, 1H, HA5), 7.21 (m, 3H, HC5+D5+B5), 6.83 (ddd, J = 7.2, 5.7, 
1.4 Hz, 1H, HE5), 6.46 (dd, J = 8.5, 2.6 Hz, 1H, HF4), 5.84 (d, J 
= 2.6 Hz, 1H, HF6), 3.52 (s, 3H, HOMe). 13C{1H} NMR (126 
MHz, CD3CN) δ/ppm: 196.4 (CF1), 168.0 (CE2), 160.8 (CF5), 
158.7 (CB2), 158.0 (CC2), 157.7 (CD2), 156.2 (CA2), 155.0 (CB6), 
151.2 (CD6), 151.1 (CC6), 151.0 (CE6), 150.2 (CA6), 139.4 (CF2), 
137.3 (CA4), 136.6 (CE4), 135.9 (CB4), 134.7 (CC4), 134.6 (CD4), 
128.0 (CA5), 127.3 (CC5), 127.2 (CB5), 127.0 (CD5), 126.5 (CF3), 
124.4 (CB3), 124.2 (CA3), 124.0 (CD3), 123.9 (CC3), 122.1 (CE5), 
120.5 (CF6), 119.0 (CE3), 107.7 (CF4), 55.1 (COMe). ESI-MS m/z: 
598.3 [M–PF6]+ (calc. 598.1). UV-Vis (MeCN, 1 × 10–5 M) 
λ/nm (ε/dm3 mol−1 cm−1): 252 (37100), 296 (70800), 372 
(11500), 398 (10900), 486 (8100), 547 (9400). Emission 
(MeCN, 5 × 10-5 M, λexc = 570 nm): λmaxem = 800 nm. Found C 
51.92, H 3.82, N 9.37; C32H26F6N5OPRu requires C 51.76, H 
3.53, N 9.43. 
[Ru(bpy)2(4)][PF6] 
cis-[Ru(bpy)2Cl2] (120 mg, 0.247 mmol), H4 (116 mg, 0.543 
mmol) and AgPF6 (137 mg, 0.543 mmol) were dissolved in 
CH2Cl2/MeOH (3:1, 16 mL) and the solution heated at reflux 
for 2 h. The mixture was filtered through Celite, the volume of 
the filtrate reduced, and flash chromatography (Al2O3, 
acetone/pentane 1:2 changing to acetone) used for purifiaction. 
The fractions were concentrated, and n-hexane was added to 
precipitate dark purple [Ru(bpy)2(4)][PF6] (95 mg, 0.123 mmol, 
50%). 1H NMR (500 MHz, CD3CN) δ/ppm: 8.46 (dt, J = 8.3, 
1.1 Hz, 1H, HA3), 8.38 (ddd, J = 8.2, 1.3, 0.7 Hz, 1H, HB3), 8.34 
(ddd, J = 8.2, 1.4, 0.8 Hz, 1H, HC3), 8.31 (ddd, J = 8.2, 1.4, 0.8 
Hz, 1H, HD3), 8.10 (dt, J = 8.2, 1.3 Hz, 1H, HE3), 7.99 (m, 2H, 
HB6+A4), 7.92 (d, J = 8.0 Hz, 1H, HF3), 7.85 (m, 2H, HC4+A6), 
7.83-7.72 (m, 5H, HB4+D4+D6+E4+C6), 7.63 (ddd, J = 5.7, 1.6, 0.8 
Hz, 1H, HE6), 7.49 (dd, J = 8.1, 1.8 Hz, 1H, HF4), 7.41 (ddd, J = 
7.6, 5.4, 1.2 Hz, 1H, HA5), 7.25 (ddd, J = 7.6, 5.7, 1.4 Hz, 1H, 
HC5), 7.20 (m, 2H, HD5+B5), 7.08 (dd, J = 1.8, 0.5 Hz, 1H, HF6), 
7.00 (ddd, J = 7.2, 5.6, 1.4 Hz, 1H, HE5), 3.69 (s, 3H, HCO2Me). 
13C{1H} NMR (126 MHz, CD3CN) δ/ppm: 193.7 (CF1), 168.5 
(CCO2Me), 167.2 (CE2), 158.6 (CB2), 157.8 (CC2), 157.6 (CD2), 
156.1 (CA2), 155.2 (CB6), 151.7 (CE6), 151.5 (CF2), 151.3 (CD6), 
151.1 (CC6), 150.1 (CA6), 137.5 (CA4), 136.9 (CE4), 136.7 (CF6), 
136.1 (CB4), 135.1 (CC4), 134.9 (CD4), 129.8 (CF5), 128.0 (CA5), 
127.5 (CC5), 127.4 (CB5), 127.2 (CD5), 124.6 (CF3), 124.5 (CB3), 
124.3 (CE5), 124.2 (CA3), 124.1 (CD3), 124.0 (CC3), 122.9 (CF4), 
121.0 (CE3), 52.3 (CCO2Me). ESI-MS m/z: 626.4 [M–PF6]+ (calc. 
626.1). UV-Vis (MeCN, 1 × 10–5 M) λ/nm (ε/dm3 mol−1 cm−1): 
250 (31600), 296 (70900), 360 (10900), 395 (7800), 485 
(9400), 538 (10000). Emission (MeCN, 5 × 10–5 M, λexc = 565 
nm): λmaxem = 781 nm. Found C 50.93, H 3.57, N 9.33; 
C33H26F6N5O2PRu requires C 51.43, H 3.40, N 9.09. 
[Ru(bpy)2(5)][PF6] 
cis-[Ru(bpy)2Cl2] (152 mg, 0.314 mmol), H5 (168 mg, 0.691 
mmol) and AgPF6 (175 mg, 0.691 mmol) were dissolved in 
CH2Cl2/MeOH (3:1, 20 mL) and the solution heated at reflux 
for 2 h. The reaction mixture was filtered through Celite, and 
the solution concentrated under reduced pressure and purified 
by flash chromatography (Al2O3, EtOAc/pentane 1:4 changing 
to acetone). The fractions were concentrated under reduced 
pressure and [Ru(bpy)2(5)][PF6] was precipitated by addition of 
n-pentane. [Ru(bpy)2(5)][PF6] was isolated as a dark purple 
solid (67 mg, 0.083 mmol, 26%). 1H NMR (500 MHz, CD3CN) 
δ/ppm: 8.46 (dt, J = 8.2, 1.1 Hz, 1H, HA3), 8.39 (dt, J = 8.1, 1.2 
Hz, 1H, HB3), 8.32 (dt, J = 8.2, 1.1 Hz, 1H, HC3), 8.28 (dt, J = 
8.2, 1.1 Hz, 1H, HD3), 8.05 (ddd, J = 5.7, 1.6, 0.7 Hz, 1H, HB6), 
8.02 (dt, J = 8.2, 1.1 Hz, 1H, HE3), 7.99 (ddd, J = 8.2, 7.6, 1.6 
Hz, 1H, HA4), 7.91 (ddd, J = 5.4, 1.6, 0.8 Hz, 1H, HA6), 7.84-
7.75 (m, 5H, HC4+B4+D6+F3+D4), 7.70 (m, 2H, HC6+E4), 7.58 (ddd, 
J = 5.6, 1.6, 0.8 Hz, 1H, HE6), 7.42 (ddd, J = 7.6, 5.4, 1.2 Hz, 
1H, HA5), 7.24-7.18 (m, 3H, HC5+D5+B5), 7.00 (dd, J = 8.0, 1.8 
Hz, 1H, HF4), 6.95 (ddd, J = 7.2, 5.7, 1.4 Hz, 1H, HE5), 6.45 (d, 
J = 1.8 Hz, 1H, HF6), 1.05 (s, 9H, HtBu). 13C{1H} NMR (126 
MHz, CD3CN) δ/ppm: 193.9 (CF1), 167.7 (CE2), 158.7 (CB2), 
157.9 (CC2), 157.6 (CD2), 156.1 (CA2), 155.0 (CB6), 151.4 (CE6), 
151.2 (CD6), 151.0 (CC6), 150.3 (CA6), 146.9 (CF2), 144.3 (CF6), 
137.4 (CA4), 136.8 (CE4), 136.0 (CB4), 134.9 (CC4), 134.7 (CD4), 
134.0 (CF5), 130.0 (CF4), 128.0 (CA5), 127.4 (CC5), 127.2 (CB5), 
127.1 (CD5), 124.8 (CF3), 124.5 (CB3), 124.2 (CA3), 124.0 (CC3), 
123.9 (CD3), 123.6 (CE5), 120.2 (CE3), 46.2 (CSCMe3), 31.3 
(CtBu). ESI-MS m/z: 656.4 [M–PF6]+ (calc. 656.1). UV-Vis 
(MeCN, 1 × 10–5 M) λ/nm (ε/dm3 mol−1 cm−1): 249 (34500), 
296 (65400), 362 (12200), 395 (10100), 492 (9900), 541 
(10500). Emission (MeCN, 5 × 10–5 M, λexc = 570 nm): λmaxem 
= 792 nm. Found C 52.19, H 4.41, N 8.61; C35H32F6N5PRuS 
requires C 52.50, H 4.03, N 8.75.  
[Ru(bpy)2(6)][PF6] 
cis-[Ru(bpy)2Cl2] (50.0 mg, 0.103 mmol), H6 (52.0 mg, 0.223 
mmol) and AgBF4 (46.0 mg, 0.236 mmol) were dissolved in 
CH2Cl2 (7.5 mL) and the dark purple solution heated at reflux 
for 24 h. After filtration through Celite, the volume of the 
solution was reduced and n-hexane (50 mL) was added to the 
dark purple oily residue; the mixture was left in the refrigerator 
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overnight. The solution was decanted and the dark purple-red 
precipitate dried under reduced pressure. The residue was 
dissolved in MeCN (10 mL) and an excess of aqueous NH4PF6 
was added. The precipitate was separated by filtration, washed 
with H2O and Et2O and redissolved with CH2Cl2. The solution 
was concentrated under reduced pressure and purified by flash 
chromatography (Al2O3, acetone/toluene 1:1 changing to 
acetone). [Ru(bpy)2(6)][PF6] was isolated as a dark purple solid 
(23 mg, 0.029 mmol, 28%). 1H NMR (500 MHz, CD3CN) 
δ/ppm: 8.46 (dt, J = 8.3, 1.0 Hz, 1H, HA3), 8.39 (dt, J = 8.1, 1.0 
Hz, 1H, HB3), 8.36 (dt, J = 8.2, 1.1 Hz, 1H, HC3), 8.32 (dt, J = 
8.2, 1.0 Hz, 1H, HD3), 8.15 (dt, J = 8.3, 1.0 Hz, 1H, HE3), 8.01 
(d, J = 8.2 Hz, 1H, HF3), 8.00 (ddd, J = 8.2, 7.6, 1.6 Hz, 1H, 
HA4), 7.97 (ddd, J = 5.7, 1.6, 0.7 Hz, 1H, HB6), 7.87 (ddd, J = 
8.2, 7.6, 1.5 Hz, 1H, HC4), 7.85-7.73 (m, 6H, H 
B4+A6+D4+E4+D6+C6), 7.65 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, HE), 7.42 
(ddd, J = 7.6, 5.4, 1.2 Hz, 1H, HA5), 7.38 (dd, J = 8.2, 2.0 Hz, 
1H, HF4), 7.27 (ddd, J = 7.3, 5.7, 1.4 Hz, 1H, HC5), 7.24-7.20 
(m, 2H, HD5+B5), 7.04 (ddd, J = 7.3, 5.7, 1.3 Hz, 1H, HE5), 6.93 
(d, J = 1.9 Hz, 1H, HF6), 2.84 (s, 3H, HMe). 13C{1H} NMR (126 
MHz, 295 K, CD3CN) δ/ppm: 196.2 (CF1), 166.5 (CE2), 158.5 
(CB2), 157.8 (CC2), 157.6 (CD2), 156.1 (CA2), 155.3 (CB6), 152.1 
(CF2), 151.8 (CE6), 151.4 (CD6), 151.2 (CC6), 150.2 (CA6), 140.3 
(CF5), 137.6 (CA4), 137.0 (CE4), 136.2 (CB4), 135.4 (CC4), 135.3 
(CD4), 133.4 (CF6), 128.1 (CA5), 127.6 (CC5), 127.5 (CB5), 127.3 
(CD5), 124.9 (CF3), 124.8 (CE5), 124.5 (CB3), 124.3 (CA3), 124.2 
(CD3), 124.1 (CC3), 121.3 (CE3), 120.1 (CF4), 44.5 (CMe). ESI-
MS m/z: 646.4 [M–PF6]+ (calc. 646.1). UV-Vis (MeCN, 1 × 10–
5 M) λ/nm (ε/dm3 mol−1 cm−1): 248 (28400), 295 (58100), 358 
(10100), 393 (6900), 485 (8500), 530 (8700). Emission 
(MeCN, 5 × 10–5 M, λexc = 555 nm): λmaxem = 760 nm. Found C 
48.57, H 3.99, N 8.38; C32H26F6N5O2PRuS requires C 48.61, H 
3.31, N 8.86. 
[Ru(bpy)2(7)][PF6] 
cis-[Ru(bpy)2Cl2] (103 mg, 0.213 mmol), H7 (100 mg, 0.469 
mmol) and AgPF6 (119 mg, 0.469 mmol) were dissolved in 
CH2Cl2/MeOH (3:1, 16 mL) and the solution heated at reflux 
for 4 h. The mixture was filtered through Celite and the filtrate 
volume reduced before flash chromatography (Al2O3, 
acetone/pentane 1:2 changing to acetone). The fractions were 
concentrated and n-hexane was added to precipitate dark purple 
solid [Ru(bpy)2(7)][PF6] (104 mg, 0.135 mmol, 63%). 1H NMR 
(500 MHz, 295 K, CD3CN) δ/ppm: 8.46 (dt, J = 8.2, 1.1 Hz, 
1H, HA3), 8.43 (dd, J = 1.8, 0.7 Hz, 1H, HE3), 8.38 (ddd, J = 
8.2, 1.4, 0.8 Hz, 1H, HB3), 8.34 (ddd, J = 8.3, 1.4, 0.8 Hz, 1H, 
HC3), 8.30 (ddd, J = 8.2, 1.4, 0.8 Hz, 1H, HD3), 7.98 (m, 2H, 
HB6+A4), 7.95 (dd, J = 7.7, 1.2 Hz, 1H, HF3), 7.86-7.77 (m, 5H, 
H C4+A6+B4+E6+D4), 7.74 (ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HD6), 7.71 
(ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HC6), 7.42 (ddd, J = 7.6, 5.4, 1.2 
Hz, 1H, HA5), 7.33 (dd, J = 5.9, 1.9 Hz, 1H, HE5), 7.24 (ddd, J = 
7.5, 5.7, 1.4 Hz, 1H, HC5), 7.19 (m, 2H, HB5+D5), 6.93 (ddd, J = 
7.8, 7.2, 1.3 Hz, 1H, HF4), 6.86 (td, J = 7.3, 1.4 Hz, 1H, HF5), 
6.47 (ddd, J = 7.4, 1.3, 0.6 Hz, 1H, HF6), 3.91 (s, 3H, HMe). 
13C{1H} NMR (126 MHz, CD3CN) δ/ppm: 194.4 (CF1), 169.7 
(CE2), 163.4 (CCO2Me), 158.6 (CB2), 157.4 (CD2), 157.5 (CC2), 
156.0 (CA2), 155.3 (CB6), 152.3 (CE6), 151.3 (CD6), 150.9 (CC6), 
150.1 (CA6), 145.9 (CF2), 137.6 (CA4), 137.0 (CE4), 136.32 
(CF6), 136.28 (CB4), 135.2 (CC4), 134.9 (CD4), 129.9 (CF5), 
128.1 (CA5), 127.5 (CC5), 127.4 (CB5), 127.1 (CD5), 125.7 (CF3), 
124.5 (CB3), 124.2 (CA3), 124.1 (CD3), 124.0 (CC3), 122.0 (CF4), 
121.7 (CE5), 118.4 (CE3), 53.4 (CCO2Me). ESI-MS m/z: 626.4 
[M–PF6]+ (calc. 626.1). High resolution ESI-MS m/z: 626.1132 
(calc. 626.1133). UV-Vis (MeCN, 1 × 10–5 M) λ/nm (ε/dm3 
mol−1 cm−1): 250 (34800), 296 (55100), 322 (10400), 368 
(8800), 438 (9100), 499 (12800). Emission (MeCN, 5 × 10–5 M, 
λexc = 575 nm): λmaxem = 784 nm. Found C 50.44, H 3.75, N 
8.77; C33H26F6N5O2PRu.H2O requires C 50.26, H 3.58, N 8.88. 
[Ru(bpy)2(8)]  
The compound was prepared adapting a previously described 
procedure for similar complexes.11 [Ru(bpy)2(7)][PF6] (20 mg, 
0.0260 mmol) was dissolved in DMF/H2O/NEt3 (3:1:1, 12 mL) 
and heated at reflux for 16 h. The solvent was removed and 
product passed through a short silica plug using MeOH/CH2Cl2 
1:1. The volume of solution was reduced and was layered with 
Et2O. After a few days, [Ru(bpy)2(8)] precipitated as a dark 
purple crystalline solid (14.2 mg, 0.0233 mmol, 89%). 1H NMR 
(500 MHz, CD3CN) δ/ppm: 8.44 (m, 2H, HA3+E3), 8.37 (d, J = 
8.2 Hz, 1H, HB3), 8.31 (d, J = 8.3 Hz, 1H, HC3), 8.28 (d, J = 8.4 
Hz, 1H, HD3), 8.07 (d, J = 5.7 Hz, 1H, HB6), 7.96 (t, J = 7.6 Hz, 
1H, HA4), 7.89 (d, J = 7.8 Hz, 1H, HF3), 7.84-7.71 (m, 6H, H 
A6+D6+C4+B4+D4+C6), 7.47 (d, J = 5.8 Hz, 1H, HE6), 7.39 (t, J = 6.5 
Hz, 1H, HA5), 7.35 (dd, J = 5.6, 1.4 Hz, 1H, HE5), 7.21-7.15 (m, 
2H, HC5+B5+D5), 6.85 (t, J = 7.4 Hz, 1H, HF4), 6.79 (t, J = 7.3, 
1H, HF5), 6.39 (d, J = 7.3 Hz, 1H, HF6). 13C{1H} NMR (126 
MHz, CD3CN) δ/ppm: 192.9 (CF1), 167.6 (CE2), 158.6 (CB2), 
157.8 (CC2), 157.7 (CD2), 156.2 (CA2), 154.9 (CB6), 151.3 (CD6), 
151.0 (CC6), 150.4 (CE6), 150.3 (CCO2), 150.0 (CA6), 149.8 
(CE4), 147.2 (CF2), 137.1 (CA4), 136.0 (CF6), 135.7 (CB4), 134.5 
(CC4), 134.2 (CD4), 129.0 (CF5), 127.9 (CA5), 127.2 (CC5), 127.1 
(CB5), 127.0 (CD5), 125.0 (CF3), 124.3 (CB3), 124.1 (CA3), 123.8 
(2C, CD3+C3), 123.3 (CE5), 121.8 (CF4), 119.3 (CE3). MALDI-
TOF MS (matrix: 4-nitroaniline) m/z: 612.3 [M + H]+ (calc. 
612.1), 568.3 [M + H – CO2]+ (calc. 568.1), 456.1 [M+H–bpy]+ 
(calc. 456.0). High resolution ESI-MS m/z: 612.0967 (calc. 
612.0976). UV-Vis (MeCN, 1 × 10–5 M) λ/nm (ε/dm3 mol−1 
cm−1): 249 (34500), 297 (48400), 365 (10800), 408 (10400), 
492 (7100), 551 (7500). Emission (MeCN, 5 × 10–5 M, λexc = 
580 nm): λmaxem = 809 nm. Satisfactory elemental analysis 
could not be obtained. 
 [Ru(bpy)2(9)][PF6] 
cis-[Ru(bpy)2Cl2] (116 mg, 0.240 mmol), H9 (194 mg, 0.528 
mmol) and AgPF6 (133 mg, 0.528 mmol) were dissolved in 
CH2Cl2 (15 mL) and the solution heated at reflux for 16 h. 
After filtration through Celite, the volume of solution was 
reduced before flash chromatography (Al2O3, acetone/pentane 
1:2 changing to acetone). The fractions were combined, the 
volume of solvent reduced, and n-hexane added to precipitate 
dark purple [Ru(bpy)2(11)][PF6] (127 mg, 0.137 mmol, 64%). 
1H NMR (500 MHz, CD3CN) δ/ppm: 8.47 (dt, J = 8.3, 1.1 Hz, 
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1H, HA3), 8.40 (ddd, J = 8.3, 1.4, 0.8 Hz, 1H, HB3), 8.33 (dt, J = 
8.3, 1.3 Hz, 1H, HC3), 8.31 (dt, J = 8.3, 1.1 Hz, 1H, HD3), 8.33 
(dd, J = 2.1, 0.7 Hz, 1H, HE3), 8.08 (ddd, J = 5.7, 1.6, 0.8 Hz, 
1H, HB6), 8.00 (m, 2H, HF3+A4), 7.90 (m, 4H, HG3+G2), 7.83 (m, 
4H, HA6+D6+C4+B4), 7.78 (ddd, J = 8.2, 7.5, 1.5 Hz, 1H, HD4), 
7.74 (ddd, J = 5.7, 1.5, 0.8 Hz, 1H, HC6), 7.64 (dd, J = 6.0, 0.7 
Hz, 1H, HE6), 7.43 (ddd, J = 7.6, 5.4, 1.2 Hz, 1H, HA5), 7.22 (m, 
4H, HD5+C5+E5+B5), 6.92 (ddd, J = 7.7, 7.2, 1.3 Hz, 1H, HF4), 
6.85 (td, J = 7.3, 1.3 Hz, 1H, HF5), 6.46 (ddd, J = 7.3, 1.3, 0.6 
Hz, 1H, HF6), 4.08 (m, 4H, HPO(OCH2Me)2), 1.29 (m, 6H, 
HPO(OCH2Me)2). 13C{1H} NMR (126 MHz, CD3CN) δ/ppm: 193.8 
(CF1), 168.9 (CE2), 158.7 (CB2), 157.72 (CC2), 157.66 (CD2), 
156.1 (CA2), 155.2 (CB6), 151.7 (CE6), 151.2 (CD6), 150.9 (CC6), 
150.2 (CA6), 147.0 (CE4), 146.6 (CF2), 142.1 (d, JPC = 3.2 Hz, 
CG1), 137.4 (CA4), 136.4 (CF6), 136.0 (CB4), 134.9 (CC4), 134.7 
(CD4), 133.2 (d, JPC = 10.0 Hz, 2C, CG2), 130.9 (d, JPC = 188 
Hz, CG4), 129.5 (CF5), 128.3 (d, JPC = 15.0 Hz, 2C, CG3), 128.1 
(CA5), 127.4 (CC5), 127.3 (CB5), 127.0 (CD5), 125.4 (CF3), 124.5 
(CB3), 124.2 (CA3), 124.0 (CD3), 123.9 (CC3), 122.0 (CF4), 121.1 
(CE5), 117.4 (CE3), 63.1 (d, JPC = 5.6 Hz, CPO(OCH2Me)2), 16.7 (d, 
JPC = 6.2 Hz, CPO(OCH2Me)2). 31P NMR (162 MHz, CD3CN) 
δ/ppm: 17.0 (PPO(OEt)2), –144.6 (hept, JPF = 706 Hz, PPF6). ESI-
MS m/z: 780.5 [M–PF6]+ (calc. 780.2). UV-Vis (MeCN, 1 × 10–
5 M) λ/nm (ε/dm3 mol−1 cm−1): 253 (45700), 297 (53600), 371 
(10800), 430 (12800), 491 (11900), 537 (10700). Emission 
(MeCN, 5 × 10-5 M, λexc = 570 nm): λmaxem = 798 nm. Found C 
52.36, H 4.58, N 7.12; C41H37F6N5O3P2Ru·H2O requires C 
52.23, H 4.17, N 7.43. 
 
Scheme	1.		Structure	of	Hppy	and	4-phenyl-functionalized	derivatives.	
 
Scheme		2.		Structures	of	cyclometallating	ligands	with	anchoring	domains.	
Crystallography 
Single crystal data were collected on a Bruker APEX-II 
diffractometer with data reduction, solution and refinement 
using the programs APEX,29 and CRYSTALS30 or SHELX-
13.31 ORTEP diagrams and structure analysis used Mercury v. 
3.0.32,33 For [Ru(bpy)2(4)][PF6].MeCN, SQUEEZE34 was used 
as one disordered solvent molecule could not be modelled in a 
satisfactory way. 
[Ru(bpy)2(4)][PF6].MeCN  
C35H29F6N6O2PRu, M = 811.69, purple plate, triclinic, space 
group P–1, a = 10.6299(10), b = 13.1587(12), c = 14.0271(13) 
Å, α = 82.634(3), β = 73.460(3), γ = 75.358(3)o, U = 1816.4(3) 
Å3, Z = 2, Dc = 1.484 Mg m–3, µ(Cu-Kα) = 4.534 mm−1, T = 
123 K. Total 22665 reflections, 6412 unique, Rint = 0.034. 
Refinement of 6300 reflections (488 parameters) with I >3σ (I) 
converged at final R1 = 0.0373 (R1 all data = 0.0377), wR2 = 
0.0571 (wR2 all data = 0.0587), gof = 1.1954. CCDC 1011911. 
[Ru(bpy)2(5)][PF6]  
C35H32F6N5PRuS, M = 800.77, black plate, triclinic, space 
group P–1, a = 9.1746(6), b = 13.7422(9), c = 13.9635(9) Å, 
α = 77.596(2), β = 75.777(2), γ = 81.750(2)o, U = 1659.04(19) 
Å3, Z = 2, Dc = 1.603 Mg m–3, µ(Cu-Kα) = 5.469 mm−1, T = 
123 K. Total 21787 reflections, 5911 unique, Rint = 0.0293. 
Refinement of 5747 reflections (445 parameters) with I >2σ (I) 
converged at final R1 = 0.0243 (R1 all data = 0.0250), wR2 = 
0.0618 (wR2 all data = 0.0622), gof = 1.043. CCDC 1011912. 
[Ru(bpy)2(7)][PF6]  
C33H26F6N5O2PRu, M = 770.63, red needle, monoclinic, space 
group P21/n, a = 12.9211(7), b = 16.9306(10), c = 15.0031(9) 
Å, β = 108.261(2)o, U = 3116.8(3) Å3, Z = 4, Dc = 1.642 Mg m–
3, µ(Cu-Kα) = 5.239 mm−1, T = 123 K. Total 53663 reflections, 
5856 unique, Rint = 0.0384. Refinement of 5340 reflections (435 
parameters) with I >2σ (I) converged at final R1 = 0.0248 (R1 
all data = 0.0276), wR2 = 0.0642 (wR2 all data = 0.0664), gof = 
1.047. CCDC 1011910. 
Results	and	conclusions	
Cyclometallating ligands with anchoring domains 
One convenient method of preparing carboxylic acid and 
phosphonic acid functionalized bpy and ppy ligands is via 
deprotection of the corresponding esters.18,35,36 The ester H7 
and carboxylic acid H28 (Scheme 2) were prepared according to 
literature methods, and their spectroscopic signatures were in 
accord with those reported.28 The introduction of phenyl 
spacers between metal-binding and anchoring domains is 
beneficial in both n- and p-type dyes,14,36 and ligand H9 was 
designed with this in mind. The precursor to H9 was 2-phenyl-
4-(4-bromophenyl)pyridine which was prepared as shown in 
Scheme 3. The intermediate 2-phenyl-4-(4-
bromophenyl)pyridine-6-carboxylic acid was prepared by 
adapting literature methods for similar compounds.37,38 
Decarboxylation by heating in ethane-1,2-diol gave the desired 
product in good yield. The 1H and 13C NMR spectra of a CDCl3 
solution of 2-phenyl-4-(4-bromophenyl)pyridine were 
consistent with the structure shown in Scheme 3. Attempts to 
obtain an electrospray mass spectrum using a conventional 
instrument were not successful, but use of an LC-ESI 
N
R
Hppy     R = H
H1    R = F
H2    R = Me
H3    R = OMe
H4    R = CO2Me
H5    R = StBu
H6    R = SO2Me
N
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combination gave a base peak at m/z 310.0 arising from the 
[M+H]+ ion.  
 Scheme 4 shows the route to phosphonate ester H9 which is 
based on the method of Odobel and coworkers39 and has been 
successfully applied to prepare a related phosphonic ester-
functionalized bpy containing phenyl spacers.36 The base peak 
in the electrospray mass spectrum of H9 and the next most 
intense peak (m/z 390.4 and 368.4) arose from [M+Na]+ and 
[M+H]+, respectively. The 1H and 13C NMR spectra were 
assigned by 2D techniques and were consistent with the 
structure in Scheme 4. The phosphonate ester was characterized 
in the 31P{1H} NMR spectrum by a singlet at ∂ –17.1 ppm.  
 
Scheme	 3.	 Synthesis	 of	 2-phenyl-4-(4-bromophenyl)pyridine,	 precursor	 to	 H9.	
Conditions:	 (i)	 Na[MeC(O)CO2],	 KOH,	 EtOH/H2O	 4:1,	 0	
oC,	 3	 h;	 (ii)	 NH4OAc(aq),	
100	oC,	6h;	(iii)	ethane-1,2-diol,	200	oC,	24	h.	 		
 
Scheme	4.	 Synthesis	 of	H9.	 Conditions:	 (i)	 [Pd(PPh3)4],	 Cs2CO3,	HPO(OEt)2,	 THF,	
microwave,	110	°C,	90	min.	
[Ru(bpy)2(C^N)][PF6] with C^N = 1–6: synthesis, NMR 
spectroscopic and structural characterizations 
The range of C^N ligands incorporated both electron-
withdrawing and donating groups. The archetype complex 
[Ru(bpy)2(ppy)][PF6] and its derivatives [Ru(bpy)2(C^N)][PF6] 
with C^N = 1–6 were prepared using a strategy reported 
previously by one of us.1 The reaction of cis-[Ru(bpy)2Cl2] with 
the cyclometallating ligand is carried out in the presence of a 
silver(I) salt (typically AgPF6 or AgBF4)1 to abstract the 
chloride ions. After work up, the cyclometallated complexes 
were obtained in yields ranging from 26% (C^N = 5) to 60% 
(C^N = 2).  
 The base peak in the ESI mass spectrum of each complex 
was assigned to [M–PF6]+ and was dominated by the 
characteristic isotope pattern of ruthenium. The 1H and 13C 
NMR spectra of CD3CN solutions of the complexes were 
recorded at room temperature. The spectra were assigned using 
a combination of COSY, HMQC, HMBC and NOESY 
methods. The aromatic regions of the 1H NMR spectra of 
[Ru(bpy)2(C^N)][PF6] with C^N = 1–6  were similar and the 
spectrum of [Ru(bpy)2(5)][PF6] is shown in Fig. 1 as a 
representative example. The presence of the cyclometallating 
ligand renders the two bpy-ligands  inequivalent (Scheme 5). In 
the NOESY spectrum, cross-peaks observed between the 
signals for HB6, HC6 and HF6 as well as between signals for HA6, 
HD6 and HE6 were especially useful during signal assignment. In 
Fig. 1, the lowest frequency doublet (J = 1.8 Hz) was assigned 
to HF6. A change in the substituent R (Scheme 5) most strongly 
influences the signals for the ring F protons and to a smaller 
extent those of ring E. For example, the chemical shift for HF6 
appears at ∂ 6.41 ppm for C^N = ppy, ∂ 6.05 ppm for 1 (fluoro 
substituent), ∂ 6.24 ppm for 2 (Me), ∂ 5.84 ppm for 3 (OMe), ∂ 
7.08 ppm for 4 (CO2Me), ∂ 6.45 ppm for 5 (StBu), and ∂ 6.93 
ppm for 6 (SO2Me). 
 
Scheme	 5.	 Atom	 numbering	 for	 NMR	 spectroscopic	 assignments	 in	 complexes	
with	ligands	ppy,	1-6	;	an	analogous	scheme	is	used	for	complexes	with	ligands	7,	
8	and	9	with	the	phenyl	spacer	ring	labelled	G	in	ligand	9.	
 The sharp, well resolved spectrum shown in Fig. 1 is typical 
of a complex which has been recrystallized, or of a sample that 
has been standing in MeCN solution for several days followed 
by filtration through Celite. Immediately after chromatographic 
workup, the 1H NMR spectrum of several of the 
[Ru(bpy)2(C^N)][PF6] complexes, notably those with ligands 2 
and 3 (Me and OMe substituents) exhibited sharp signals for 
the coordinated bpy ligands and broad signals for the C^N 
ligand. Over time, the signals sharpened (Fig. 2) and very small 
amounts of a colourless solid were observed in the NMR tube. 
 One possible explanation is that ion-pairing involving 
residual chloride ion might be the origin of the phenomenon. 
However, addition of [nBu4N]Cl led only to shifts in the H3 
protons of  bpy (Fig. 3), consistent with the established anion-
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binding by these bpy protons in ruthenium(II)40 and iridium(III) 
complexes.41 We suggest that interactions between Ag+ and the 
coordinated C^N ligand may be responsible for the broadening 
of the HE5, HF4  and HF6 proton signals. Interactions between 
Ag+ and an aromatic π-system are documented and result in 
similar effects on 1H NMR spectra.42 Attempts to gain further 
insight into the phenomenon were unsuccessful. No silver 
adduct could be detected by mass spectrometry. Attempts to 
measure 109Ag NMR spectra were unsuccessful; the sensitivity 
of the 109Ag nucleus in CD3CN solution is very low and 
longitudinal relaxation times (T1) were too long to run 
reasonable experiments even when relaxation agents were 
added. We cannot rule out the possibility that Ag+ oxidizes 
Ru2+ to Ru3+ and that the changes in the 1H NMR spectra arise 
from the presence of the paramagnetic Ru3+ ion (d5). However, 
addition of Br2 to [Ru(bpy)2(3)][PF6] results in the appearance 
of signals between the limits of ∂ +23 and –34 ppm which is 
consistent with data reported for polypyridyl µ-oxo complexes 
of ruthenium(III),43 and does not show selective broadening and 
shifting of signals for the 2-phenylpyridine ligand protons. 
 
 
Fig.	1	 	Aromatic	 region	of	 the	500	MHz	 1H	NMR	spectrum	of	 [Ru(bpy)2(5)][PF6]	
(CD3CN,	295	K).	See	Scheme	5	for	the	atom	labelling	scheme.	Chemical	shifts	in	∂	
/	ppm.	
 
Fig.	2.	Time	dependence	of	the	400	MHz	1H	NMR	spectrum	(aromatic	region)	of	
[Ru(bpy)2(3)][PF6]	in	CD3CN	(295	K).	Chemical	shifts	in	∂	/	ppm.	
 
Fig.	 3.	 Room	 temperature	 400	 MHz	 1H	 NMR	 spectrum	 (aromatic	 region)	 of	 a	
CD3CN	 solution	 of	 (a)	 [Ru(bpy)2(3)][PF6]	 and	 (b)	 after	 addition	 of	 an	 excess	 of	
[nBu4N]Cl.	Chemical	shifts	in	∂	/	ppm.	See	Scheme	5	for	atom	labelling.	
 We note that in order to ensure sharp signals in the 1H NMR 
spectrum of the [Ru(bpy)2(C^N)][PF6] complexes, it is essential 
either to recrystallize the complex or to dissolve the complex in 
MeCN and leave the solution to stand for at least a week; 
filtration through Celite separates precipitated silver(I) salts. 
 Rather surprisingly, the number of structurally characterized 
[Ru(N^N)2(C^N)]+ complexes (N^N = bpy or phen-based 
chelate, C^N = ppy or derivative of ppy) is limited to only 19 
entries in the Cambridge Structural Database44 (v. 5.35 with 
November 2013, February and May 2014 updates, searched 
using Conquest v. 1.1632). Single crystals of 
[Ru(bpy)2(4)][PF6].MeCN and [Ru(bpy)2(5)][PF6]  were grown 
by diffusion of Et2O into MeCN solutions of the complexes. 
The chiral tris-chelates crystallize in the centrosymmetric P–1 
space group with both enantiomers of the octahedral cation 
present in the unit cell. The structures of Δ-[Ru(bpy)2(4)]+ and 
Δ-[Ru(bpy)2(5)]+ are shown in Figs. 4 and 5 and important bond 
distances are listed in the captions. The bond parameters within 
each ruthenium(II) coordination sphere are similar to those in 
[Ru(bpy)2(ppy)][PF6].45,46 One of the disordered solvent 
molecules in [Ru(bpy)2(4)][PF6].MeCN was modelled over two 
sites of occupancies 68 and 32%. The second could not be 
modelled in a satisfactory way and SQUEEZE34 was therefore 
used to treat the data. The [PF6]– anions in both structures are 
ordered.  
 The cations in [Ru(bpy)2(4)][PF6].MeCN are aligned along 
the a-axis with the methyl group (C33) of the ester functionality 
sandwiched between pyridine rings containing N4i and N5i 
(Fig. 6a, symmetry code i = 1+x, y, z). The C33...centroid 
distances are 3.41 and 4.07 Å. This packing interaction is 
augmented by face-to-face (rings with N1 and N1ii, symmetry 
code ii = 1–x, 2–y, –z) and edge-to-face (rings with N1 and 
C31ii) contacts between enantiomeric pairs of cations (Fig. 6b).  
For the face-to-face contact, the separation of the ring planes is 
3.51 Å and inter-centroid separation is 3.84 Å. The packing in 
[Ru(bpy)2(5)][PF6] features an analogous embrace between 
enantiomers with the distance between the ring planes (rings 
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with N5 and N5i, symmetry code i = –x, 2–y, 1–z) and inter-
centroid separation being 3.47 Å and 3.83 Å for the face-to-face 
π-stacking interaction. The [Ru(bpy)2(5)]+ cations also engage 
in a second embrace involving pyridine rings containing N4 
and N4ii (symmetry code ii = 1–x, 2–y, –z), but as Fig. 6c 
shows, slippage of the rings caused by steric demands of the 
tBu groups results in the π–π stacking interaction being 
inefficient (inter-plane and inter-centroid distances = 3.14 and 
4.60 Å, respectively).   
 
Fig.	 4.	 Structure	 of	 the	Δ-[Ru(bpy)2(4)]
+	 cation	 in	 [Ru(bpy)2(4)][PF6]
.MeCN	with	
ellipsoids	 plotted	 at	 40%	 probability	 level	 and	 H	 atoms	 omitted	 for	 clarity.	
Selected	 bond	 parameters:	 Ru1–N1	 =	 2.050(2),	 Ru1–N2	 =	 2.035(3),	 Ru1–N3	 =	
2.140(2),	Ru–N4	=	2.066(3),	Ru1–N5	=	2.068(3),	Ru1–C31	=	2.025(3),	C29–C32	=	
1.485(4),	O1–C32	=	1.207(4),	O2–C32	=	1.325(4),	O2–C33	=	1.450(4)	Å;	N1–Ru1–
N2	=	78.89(11),	N3–Ru1–N4	=	77.26(10),	N5–Ru1–C31	=	79.63(11),	O2–C32–O1	=	
122.0(3)o.	
 
 
Fig.	5.	Structure	of	the	Δ-[Ru(bpy)2(5)]
+	cation	in	[Ru(bpy)2(5)][PF6]	with	ellipsoids	
plotted	at	40%	probability	 level	and	H	atoms	omitted	for	clarity.	Selected	bond	
distances	 and	 angles:	 Ru1–N5	 =	 2.0464(16),	 Ru1–N4	 =	 2.0490(15),	 Ru1–N2	 =	
2.0696(15),	 Ru1–N1	 =	 2.0821(16),	 Ru1–N3	 =	 2.1282(15),	 Ru1–C7	 =	 2.0326(18),	
C9–S1	=	1.7865(19),	S1–C12	=	1.864(2)	Å;	N2–Ru1–N3	=	77.32(6),	N5–Ru1–N4	=	
78.92(6),	C7–Ru1–N1	=	79.75(7),	C9–S1–C12	=	102.95(9)o.	
 
 
 
(a)	
 
(b)	 	 	 										(c)	
Fig.	 6.	 (a)	Packing	of	 [Ru(bpy)2(4)]
+	 cations	 into	 chains	along	 the	a-axis.	 (b)	π-π	
and	 CH–π	 embrace	 between	 enantiomers	 in	 [Ru(bpy)2(4)][PF6]
.MeCN,	 and	 (c)	
slipped	π-stacking	interaction	between	enantiomers	in	[Ru(bpy)2(5)][PF6].	
 
 
[Ru(bpy)2(C^N)][PF6] with C^N = 1–6: electronic spectroscopy 
and electrochemistry 
Fig. 7 compares the solution absorption spectra of 
[Ru(bpy)2(C^N)][PF6] (C^N = 1–6) with that of 
[Ru(bpy)2(ppy)][PF6]. All complexes exhibit similar spectra 
with a broad spectral response, consistent with those of related 
[Ru(bpy)2(C^N)]+ complexes.2,8,14,47 The intense bands in the 
UV region around 250 and 300 nm arise from spin-allowed 
ligand-centred π*←π transitions. The two, broad lower energy 
absorptions in the ranges 350–430 nm and 430–630 nm are 
typical of [Ru(bpy)2(C^N)]+ cations and have previously been 
assigned to MLCT bands arising from metal-to-C^N and metal-
to-bpy transitions, respectively.8,14,47 Consistent with this, Fig. 7 
and Table 1 show that the lowest energy bands are largely 
unaffected by the introduction of substituents into the 
cyclometallating ligand. Only the spectrum of 
[Ru(bpy)2(6)][PF6], which contains the electron-withdrawing 
SO2Me substituent, shows a noticeable difference (Fig. 7 and 
Table 1). The 350–430 nm absorption is most significantly 
influenced by the introduction of CO2Me or SO2Me groups 
(ligands 4 and 6, Fig. 7) and to a lesser extent by the presence 
of the sulfanyl group in 5.  
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Fig.	7.	 	Solution	absorption	spectra	 	of	[Ru(bpy)2(C^N)][PF6]	with	C^N	=	ppy	and	
1–6	(MeCN,	1	×	10–5	mol	dm–3).	
  
The room temperature photoluminescence spectra of MeCN 
solutions of the complexes show a dependence on the C^N-
substituent (Fig. 8 and Table 1). Broad, unstructured bands are 
observed. As previously reported for related complexes,8,11,47 
[Ru(bpy)2(C^N)][PF6] with C^N = 1-6 are very weak emitters 
in solution at room temperature and exhibit quantum yields of 
<1% (the limit of detection of our instrument). This is 
consistent with work of Castellano and coworkers who were 
unable to obtain reliable PLQY values for [Ru(bpy)2(ppy)][PF6] 
and related complexes due to their extremely low values.47 
Thus, we focus only on the trends in the emission maxima. 
Using [Ru(bpy)2(ppy)][PF6] as a reference point, the 
introduction of 4-methyl or 4-methoxy substituents into the 
phenyl ring of the C^N ligand has essentially no effect on 
λemmax (Table 1). A blue shift is observed when electron-
withdrawing substituents are introduced, consistent with a 
lowering of the energy of the HOMO. For the most electron-
withdrawing group (SO2Me), a blue-shift of 43 nm occurs on 
going from [Ru(bpy)2(ppy)][PF6] to [Ru(bpy)2(6)][PF6]. 
 
 
Fig.	8.		Normalized	solution	emission	spectra	of	[Ru(bpy)2(C^N)][PF6]	with	C^N	=	
ppy	and	1–6	(MeCN,	5	×	10–5	mol	dm–3).	
Table 1. MLCT-absorptiona and emissionb maxima for [Ru(bpy)2(C^N)][PF6] 
with C^N = ppy and 1–6 (MeCN solutions).  
Complex MLCT λmax / nm λexc / 
nm 
λemmax / 
nm Ru-to-C^N  Ru-to-bpy 
[Ru(bpy)2(ppy)][PF6] 369, 403 488, 546 575 803 
[Ru(bpy)2(1)][PF6] 368, 399 485, 538 560 776 
[Ru(bpy)2(2)][PF6] 372, 398 486, 547 575 805 
[Ru(bpy)2(3)][PF6] 360, 395 485, 538 570 800 
[Ru(bpy)2(4)][PF6] 362, 395 492, 541 565 781 
[Ru(bpy)2(5)][PF6] 362, 395 492, 541 570 792 
[Ru(bpy)2(6)][PF6] 358, 393 485, 530 555 760 
a Extinction coefficients for the MLCT bands are given in the experimental 
section. bDegassed solutions. 
 
Fig.	9.	Cyclic	voltammogram	of	[Ru(bpy)2(3)][PF6]	(degassed	MeCN	solution)	with	
respect	to	Fc/Fc+;	scan	rate	=	0.1	V	s–1.	
 The electrochemical data of the ruthenium(II) complexes are 
summarized in Table 2, and a representative cyclic 
voltammogram (CV) is shown in Fig. 9. Each complex 
undergoes a reversible metal-centred oxidation. The reversible 
Ru3+/Ru2+ process for [Ru(bpy)2(ppy)][PF6] occurs at +0.09 V 
versus Fc+/Fc; literature data are with respect to NHE or 
SCE.1,2,8 Introduction of electron-withdrawing substituents on 
going to [Ru(bpy)2(1)][PF6], [Ru(bpy)2(4)][PF6], 
[Ru(bpy)2(5)][PF6] and [Ru(bpy)2(6)][PF6] shifts the Ru3+/Ru2+ 
couple to higher potential in the order (for the substituents) 
SO2Me > CO2Me > F > tBuS. Introduction of the electron-
donating Me or OMe groups in [Ru(bpy)2(2)][PF6] and 
[Ru(bpy)2(3)][PF6], respectively, causes small shifts to lower 
potential. The trend in potentials for the oxidation process is 
consistent with the HOMO being centred on the metal and 
cyclometallating ligand. Each complex exhibits two, ligand-
based reversible reduction processes. The invariance of the 
potential for a given process (first or second reduction) is 
consistent with localization of the LUMO on the bpy ligands. 
For [Ru(bpy)2(6)][PF6], a third reversible reduction is observed. 
On going from [Ru(bpy)3]2+ to [Ru(bpy)2(ppy)]+, the ligand-
based reduction processes shift to lower potential as a result of 
greater π-back-bonding from the ruthenium(II) centre.8 The 
introduction of the strongly electron-withdrawing SO2Me group 
in [Ru(bpy)2(6)]+ opposes the latter, and this is consistent with 
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the appearance of a third reduction process. Note that a third 
process is present within the solvent accessible window in 
[Ru(bpy)3]2+ but not in [Ru(bpy)2(ppy)]+.8   
Table 2. Redox potentials for [Ru(bpy)2(C^N)][PF6] with C^N = ppy and 1–6 
(degassed MeCN solutions) with respect to Fc/Fc+; 0.1 M [nBu4N][PF6] as 
supporting electrolyte and a scan rate of 0.1 V s–1. 
Complex E1/2ox / 
V 
E1/2red1 
/ V 
E1/2red2 
/ V 
E1/2red3 
/ V 
ΔE1/2 / 
V 
[Ru(bpy)2(ppy)][PF6] +0.09 −1.96 −2.22  2.05 
[Ru(bpy)2(1)][PF6] +0.15 −1.97 −2.22  2.12 
[Ru(bpy)2(2)][PF6] +0.06 −1.98 −2.24  2.04 
[Ru(bpy)2(3)][PF6] +0.08 −1.98 −2.25  2.06 
[Ru(bpy)2(4)][PF6] +0.17 −1.94 −2.19  2.11 
[Ru(bpy)2(5)][PF6] +0.11 −1.98 −2.24  2.09 
[Ru(bpy)2(6)][PF6] +0.21 −1.95 −2.19 −2.43 2.16 
[Ru(bpy)2(C^N)][PF6] with C^N =  7 and 9, and [Ru(bpy)2(8)] 
The compounds [Ru(bpy)2(C^N)][PF6] with C^N = 7 and 9 
were synthesized as described for the analogues with C^N = 1-
6. The synthesis of [Ru(bpy)2(8)] employed a method described 
by Bomben et al.11 for hydrolysis of a pyridine-attached ester 
substituent; heating [Ru(bpy)2(7)][PF6] in a mixture of DMF, 
H2O and NEt3 at 100 oC for 16 hours yielded the zwitter-ion 
[Ru(bpy)2(8)] in 89% yield. For each of [Ru(bpy)2(C^N)][PF6] 
(C^N = 7 and 9), the base peak in the ESI mass spectrum arose 
from the [M – PF6]+ ion and the isotope pattern matched that 
calculated. The formation of a neutral compound [Ru(bpy)2(8)] 
with ligand H28 was supported by high resolution mass 
spectrometry and by the absence of signals for [PF6]− in the 31P 
and 19F NMR spectra. The MALDI-TOF mass spectrum of 
[Ru(bpy)2(8)] showed a peak envelope at m/z 612.3 consistent 
with [M+H]+; signals were also observed for [M+H–CO2]+ and 
[M+H–bpy]+.  
 The 1H NMR spectra of CD3CN solutions of 
[Ru(bpy)2(C^N)][PF6] (C^N = 7 and 9) showed the same 
broadening of signals observed for the complexes containing 1–
6 (see Fig. 2). Sharp spectra (illustrated  for [Ru(bpy)2(7)][PF6] 
in Fig. 10) were obtained once MeCN solutions of the product  
had been left to stand for several days and then filtered through 
Celite. In contrast, and consistent with the absence of Ag+ ions 
in the synthesis, the 1H NMR spectrum of a freshly prepared 
sample of [Ru(bpy)2(8)] showed sharp signals which did not 
shift with time. Berlinguette and coworkers have previously 
reported [Ru(bpy)2(H8)][NO3], prepared under basic conditions 
from reaction of cis-[Ru(bpy)2Cl2] and H28 in the presence of 
AgNO3.8 We note that the spectroscopic properties reported for 
[Ru(bpy)2(H8)][NO3] (NMR spectra recorded in 
CD3OD/NaOD)8 are very similar to those we observe (in 
CD3OD or in CD3CN) for [Ru(bpy)2(8)]. 
 
Fig.	 10.	 Room	 temperature	 500	MHz	 1H	NMR	 spectrum	 (aromatic	 region)	 of	 a	
CD3CN	solution	of	 [Ru(bpy)2(7)][PF6].	Chemical	 shifts	 in	∂	 /	ppm.	See	Scheme	5	
for	atom	labelling.	
 Solution 1H and 13C NMR spectra of the three complexes 
were assigned by 2D-methods. In the NOESY spectrum, cross-
peaks between signals for HB6, HC6 and HF6 and between those 
for HA6, HD6, and HE6 assisted in confirmation of ring 
assignment. For each complex, the doublet at lowest frequency 
(Fig. 10) was assigned to HF6 of the cyclometallated ring. For 
[Ru(bpy)2(9)][PF6], additional signals in the aromatic region 
were observed consistent with the presence of the phenyl spacer 
(ring G). For [Ru(bpy)2(7)][PF6], the methyl ester gives rise to 
singlets at ∂ 3.91 and 53.4 ppm in the 1H and 13C NMR spectra, 
respectively. The phosphonate ester group in 
[Ru(bpy)2(9)][PF6] gave rise to characteristic multiplets at ∂ 
4.08 and 1.29 ppm, and at ∂ 63.1 and 16.7 ppm in the 1H and 
13C NMR spectra, respectively, and a signal at ∂ 17.0 ppm in 
the 31P NMR spectrum. The reaction of cis-[Ru(bpy)2Cl2] with 
H9 to give the diester [Ru(bpy)2(9)][PF6] as the isolated 
product contrasts with the tendency of diethyl 2,2':6',2''-
terpyridine-4'-phosphonate to undergo partial hydrolysis to the 
monoester during formation of ruthenium(II) complexes.18,19,21  
 X-Ray quality single crystals of [Ru(bpy)2(7)][PF6] were 
grown by diffusion of Et2O into a CH2Cl2 solution of the 
compound. The octahedral tris(chelate) [Ru(bpy)2(7)]+ is chiral, 
and as the complex crystallizes in the centrosymmetric space 
group P21/n, both the Λ- and Δ-enantiomers are present in the 
lattice. The structure of the Λ-[Ru(bpy)2(7)]+ cation is shown in 
Fig. 11a; the figure caption gives selected bond parameters. 
Each chelating ligand deviates little from planarity; the angles 
between the planes through the rings containing N2/N3, N4/N5 
and C1/N1 = 5.1, 9.6 and 7.2o, respectively. Λ- and Δ-
[Ru(bpy)2(7)]+ cations interact through efficient π-π and CH–π 
contacts (Fig. 11b) to give a packing motif analogous to that in 
[Ru(bpy)2(4)][PF6] (Fig. 6b). For the face-to-face π-interaction 
between pyridine rings with N5 and N5i (symmetry code i = 1–
x, 1–y, 1–z), the inter-plane and inter-centroid distances are 3.30 
and 3.61 Å, respectively. The complementary edge-to-face 
contact is between the pyridine ring with N5 and the 
cyclometallated ring with C1i (C31H31...centroid = 2.41 Å). 
The different substitution pattern of the CO2Me group in the 
C^N ligand in [Ru(bpy)2(4)]+ and [Ru(bpy)2(7)]+ impacts on the 
packing interactions involving the ester group. In contrast to the 
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accommodation of the CO2Me group between pairs of pyridine 
rings in [Ru(bpy)2(4)][PF6] (Fig. 6a), methyl ester groups in 
[Ru(bpy)2(7)][PF6] are organized in head-to-tail pairs although 
the shortest C12–O1...H8Aii–C8ii contacts (2.94 Å, symmetry 
code ii = 2–x, 1–y, 2–z) are rather long to represent significant 
hydrogen bond interactions.48 
 
(a)	
 
(b)	
Fig.	 11.	 (a)	 Structure	 of	 the	 Λ-[Ru(bpy)2(7)]
+	 cation	 in	 [Ru(bpy)2(7)][PF6]	 with	
ellipsoids	 plotted	 at	 40%	 probability	 level	 and	 H	 atoms	 omitted	 for	 clarity.	
Selected	bond	parameters:	Ru1–C1	=	2.0347(19),	Ru1–N1	=	2.0614(17),	Ru1–N2	
=	2.0662(16),	Ru1–N3	=	2.1391(17),	Ru1–N4	=	2.0381(16),	Ru1–N5	=	2.0399(15),	
C9–C12	=	1.488(3),	C12–O1	=	1.205(3),	C12–O2	=	1.331(3),	O2–C13	=	1.437(3)	Å;	
C1–Ru1–N1	=	79.68(7),	N2–Ru1–N3	=	77.59(6),	N4–Ru1–N5	=	79.01(6),	O1–C12–
O2	=	124.3(2),	O2–C12–C9	=	111.14(17),	O1–C12–C9	=	124.54(19),	C12–O2–C13	
=	 116.01(18)o.	 (b)	 Efficient	 face-to-face	 and	 edge-to-face	 interactions	 between	
enantiomers	in	[Ru(bpy)2(7)][PF6].	
  
 
 Fig. 12 shows the solution absorption spectra of 
[Ru(bpy)2(7)][PF6], [Ru(bpy)2(9)][PF6] and [Ru(bpy)2(8)]. The 
intense, high-energy ligand-based absorptions (below 300 nm) 
are similar to those observed for [Ru(bpy)2(ppy)][PF6] and 
[Ru(bpy)2(C^N)][PF6] (C^N = 1–6). The enhanced intensity of 
the band at 253 nm on going from [Ru(bpy)2(7)][PF6] and 
[Ru(bpy)2(8)], to [Ru(bpy)2(9)][PF6] is consistent with the 
introduction of the phenyl spacer in the latter complex. As 
mentioned earlier, the 350–430 nm and 430–630 nm MLCT 
bands in [Ru(bpy)2(ppy)]+ arise from Ru-to-ppy and Ru-to-bpy 
transitions, respectively,8,14,47 and for the C^N ligands with 
substituents in the phenyl ring, the spectra in Fig. 7 and Table 1 
suggested an analogous partitioning of character. However, Fig. 
12 and Table 3 show that when the C^N ligand is 7 or 9, 
assignments are ambiguous. The introduction of the diethyl 
phenylenephosphonate group has the greatest influence on the 
absorption in the region (red line in Fig. 12), and improves the 
overall spectral response of the complex. 
 
 
Fig.	12.		Solution	absorption	spectra	of	[Ru(bpy)2(7)][PF6],		[Ru(bpy)2(9)][PF6]	and	
neutral	complex	[Ru(bpy)2(8)]	compared	to	[Ru(bpy)2(ppy)][PF6]	(MeCN,	1	×	10
–5	
mol	dm–3).	
 
Table 3. MLCT-absorptiona and emission maximab for [Ru(bpy)2(7)][PF6], 
[Ru(bpy)2(9)][PF6] and neutral complex [Ru(bpy)2(8)] compared to 
[Ru(bpy)2(ppy)][PF6] (MeCN solutions).  
Complex MLCT λmax / nm λexc / 
nm 
λemmax / 
nm 
[Ru(bpy)2(ppy)][PF6] 369, 403, 488, 546 575 803 
[Ru(bpy)2(7)][PF6] 322, 368, 438, 499 575 784 
[Ru(bpy)2(8)]  365, 408, 492, 551 580 809 
[Ru(bpy)2(11)][PF6] 371, 430, 491, 537 570 798 
a Extinction coefficients for the MLCT bands are given in the experimental 
section. bDegassed solutions. 
  
 The compounds [Ru(bpy)2(8)],  [Ru(bpy)2(7)][PF6] and 
[Ru(bpy)2(9)][PF6] are weakly emissive, and emission maxima 
are given in Table 3. As Fig. 13 shows, the only significant 
effect compared to [Ru(bpy)2(ppy)][PF6] (λmax = 803 nm) is 
caused by the introduction of the electron-withdrawing methyl 
ester group in [Ru(bpy)2(7)][PF6] (λmax = 784 nm), consistent 
with a lowering of the HOMO which is centred on the 
cyclometallating ligand. No such blue-shift is observed when 
the phenylene spacer is present between the electron-
withdrawing phosphonate group and the phenylpyridine 
domain.  
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Fig.	 13.	 	 Normalized	 solution	 emission	 spectra	 of	 [Ru(bpy)2(7)][PF6],	
[Ru(bpy)2(9)][PF6]	and	[Ru(bpy)2(8)]	compared	to	[Ru(bpy)2(ppy)][PF6]		(MeCN,	5	
×	10–5	mol	dm–3).	
Table 4. Cyclic voltammetric data for [Ru(bpy)2(C^N)][PF6] (C^N = ppy, 7 
and 9) and [Ru(bpy)2(8)] (degassed MeCN solutions) with respect to Fc/Fc+; 
0.1 M [nBu4N][PF6] as supporting electrolyte and a scan rate of 0.1 V s–1. 
Complex E1/2ox / 
V 
E1/2red1 
/ V 
E1/2red2 
/ V 
E1/2red3 
/ V 
ΔE1/2 / 
V 
[Ru(bpy)2(ppy)][PF6] 0.09 −1.96 −2.22  2.05 
[Ru(bpy)2(7)][PF6] 0.13 −1.95 −2.14 −2.40 2.08 
[Ru(bpy)2(8)] 0.04 −2.00 −2.27  2.04 
[Ru(bpy)2(9)][PF6] 0.08 −1.97 −2.21 −2.41 2.05 
  
 Each complex is electrochemically active and cyclic 
voltammetric data are given in Table 4; Fig. 14 shows the CV 
of [Ru(bpy)2(7)][PF6] as a representative example. Each 
compound shows a reversible metal-centred process. Compared 
to a potential of 0.09 V for the Ru3+/2+ couple in 
[Ru(bpy)2(ppy)]+, the introduction of the electron-withdrawing 
ester substituent in [Ru(bpy)2(7)]+ shifts the process to 0.13 V. 
This trend is consistent with the emission data and the lowering 
of the HOMO. The similarity of the E1/2ox values for 
[Ru(bpy)2(ppy)]+ and [Ru(bpy)2(9)]+ (Table 4) is also consistent 
with the trend in the emission maxima (Table 3). The shift to 
less positive potential for the Ru3+/2+ couple on going from 
[Ru(bpy)2(ppy)]+ to [Ru(bpy)2(8)] is consistent with the overall 
charge on the complex, and is also in line with the red-shift in 
the emission maximum (Fig. 13). Three reversible ligand-based 
reduction processes are observed for [Ru(bpy)2(7)][PF6] (Fig. 
14) and [Ru(bpy)2(9)][PF6]. On going to [Ru(bpy)2(8)], the first 
two reductions are shifted to more negative potential, and only 
two processes are observed within the electrochemical solvent 
window. 
 
 
Fig.	 14.	 Cyclic	 voltammogram	 of	 [Ru(bpy)2(7)][PF6]	 (degassed	 MeCN	 solution)	
with	respect	to	Fc/Fc+;	scan	rate	=	0.1	V	s–1.	
Conclusions		
A series of [Ru(bpy)2(C^N)][PF6] complexes with C^N = 1–7 
and 9 and the zwitter-ion [Ru(bpy)2(8)] have been prepared and 
characterized, and the crystal structures of 
[Ru(bpy)2(4)][PF6].MeCN, [Ru(bpy)2(5)][PF6] and 
[Ru(bpy)2(7)][PF6] determined. [Ru(bpy)2(C^N)]+ (C^N = 7 
and 9) and [Ru(bpy)2(8)] contain pendant domains that are 
potential anchors to semiconductor surfaces. The synthesis of 
the cationic complexes involves the use of AgPF6 to abstract 
chloride ion from the cis-[Ru(bpy)2Cl2] precursor; interactions 
between residual Ag+ and the coordinated C^N ligand in 
[Ru(bpy)2(C^N)]+ results in broadened and high-field shifted 
signals for the cyclometallated ring protons. 1H NMR signals 
are observed if the freshly prepared [Ru(bpy)2(C^N)][PF6] 
complex is dissolved in MeCN and the solution left to stand for 
at least a week followed by filtration through Celite; 
recrystallized samples also give well resolved NMR spectra. 
The absorption spectra of [Ru(bpy)2(C^N)][PF6] with C^N = 1–
6 and of [Ru(bpy)2(8)] are similar, but the introduction of the 
anchoring domains in [Ru(bpy)2(C^N)][PF6] with C^N = 7 or 9 
enhances the absorption response; the greatest influence on the 
absorption is seen with the introduction of the diethyl 
phenylenephosphonate group. Trends in emission and 
electrochemical behaviours of the complexes are readily 
interpreted in terms of the influence of the electronic properties 
of the C^N ligand substituents on the energies of the HOMO 
which is localized on the cyclometalling ligand and the 
ruthenium centre. This study has allowed us to optimize a 
synthetic route to the phosphonate ester derivative 
[Ru(bpy)2(9)][PF6] which also exhibits the most promising 
spectral response among the complexes studied.  
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